Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mutating factor VIII: lessons from structure to function.

Philip J Fay1, P Vincent Jenkins

  • 1Department of Biochemistry, School of Medicine, University of Rochester, P.O. Box 712, 601 Elmwood Ave., Rochester, NY 14642, USA. philip_fay@urmc.rochester.edu

Blood Reviews
|December 2, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phosphatidylthreonine is a procoagulant lipid detected in human blood and elevated in coronary artery disease.

Journal of lipid research·2023
Same author

Expresser phenotype determines ABO(H) blood group antigen loading on platelets and von Willebrand factor.

Scientific reports·2020
Same author

Laboratory coagulation tests and emicizumab treatment A United Kingdom Haemophilia Centre Doctors' Organisation guideline.

Haemophilia : the official journal of the World Federation of Hemophilia·2019
Same author

Laboratory measurement of factor replacement therapies in the treatment of congenital haemophilia: A United Kingdom Haemophilia Centre Doctors' Organisation guideline.

Haemophilia : the official journal of the World Federation of Hemophilia·2019
Same author

Enzymatically oxidized phospholipids restore thrombin generation in coagulation factor deficiencies.

JCI insight·2018
Same author

Noncovalent stabilization of the factor VIII A2 domain enhances efficacy in hemophilia A mouse vascular injury models.

Blood·2014
Same journal

Treating large B-cell lymphoma: Current strategies and unmet needs across community and academic settings.

Blood reviews·2026
Same journal

MRD in multiple myeloma: Moving from "minimal" to "measurable".

Blood reviews·2026
Same journal

PRISMA-based systematic review on iron stores in repeat blood donors.

Blood reviews·2026
Same journal

Artificial intelligence applications in thrombotic thrombocytopenic Purpura: A systematic review of diagnostic, risk stratification, and prognostic models.

Blood reviews·2026
Same journal

Antibacterial, antifungal and antiviral prophylaxis and vaccination strategies in adult patients with acute myeloid and promyelocytic leukemia: An expert panel consensus from the GIMEMA group.

Blood reviews·2026
Same journal

The Lebanese national patient blood management guidelines: A new page in the medical practice.

Blood reviews·2026
See all related articles

Factor VIII, a key blood clotting protein, is activated at injury sites. Understanding its structure and interactions, aided by mutations, is crucial for studying coagulation.

Area of Science:

  • Biochemistry
  • Hematology
  • Molecular Biology

Background:

  • Factor VIII is a metal ion-dependent heterodimer essential for blood coagulation.
  • It circulates bound to von Willebrand factor and is activated by limited proteolysis at sites of vascular injury.

Purpose of the Study:

  • To review novel contributions to understanding Factor VIII structure and function.
  • To highlight the role of mutations in elucidating intra- and inter-molecular interactions.

Main Methods:

  • Review of recent studies on Factor VIII.
  • Application of naturally occurring and site-directed mutations to investigate protein structure and function.
  • Identification of metal ion coordination sites and catabolic ligands.

Related Experiment Videos

Main Results:

  • Factor VIIIa assembles with factor IXa on anionic phospholipids to form the intrinsic Factor Xase complex.
  • Factor Xase efficiently converts factor X to factor Xa during coagulation propagation.
  • Mechanisms regulating Factor Xase activity include subunit dissociation and proteolytic inactivation by activated protein C.

Conclusions:

  • Investigating Factor VIII through mutations provides critical insights into its structure-function relationships.
  • Understanding these interactions is vital for comprehending coagulation and developing therapeutic strategies.